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Abstract RPB3 is a core subunit of RNA polymerase II (pol
II) that, together with the RPB11 subunit, forms the hetero-
dimer considered as a functional counterpart of the bacterial
K subunit homodimer involved in promoter recognition. We pre-
viously employed the yeast two-hybrid system and identi¢ed an
interaction between RPB3 and the myogenic transcription fac-
tor myogenin, demonstrating an involvement of this subunit in
muscle di¡erentiation. In this paper we report the interaction
between RPB3 and another known transcription factor, ATF4.
We found that the intensity of the interaction between RPB3
and ATF4 is similar to the one between RPB3 and myogenin.
This interaction involves an RPB3 speci¢c region not homolo-
gous to the prokaryotic K subunit. We demonstrated that RBP3
is able to enhance ATF4 transactivation, whereas the region of
RPB3 (Sud) that contacts ATF4, when used as a dominant
negative, markedly inhibits ATF4 transactivation activity. Inter-
estingly, ATF4 protein level, as reported for its partner RPB3,
increases during C2C7 cell line muscle di¡erentiation.
. 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
The eukaryotic heteromeric enzyme RNA polymerase II
consists of 12 di¡erent subunits [1,2]. Despite the fundamental
role of pol II in initiation, elongation, and termination of
mRNA transcription, little is known about the speci¢c func-
tions of its individual subunits, associations between subunits,
or possible contacts between subunits and holoenzyme com-
ponents and transcription factors. Indeed, in addition to the
role of the two largest subunits, RPB1 and RPB2, which are
homologous to L1 and L subunits of the bacterial enzyme and
contain the main catalytic center [3], the contributions of the
10 additional smaller subunits to the enzymatic functions are
still not well characterized [4^7].
We have previously cloned two subunits of human pol II
core, RPB11 and RPB3, and have shown the involvement of
these proteins in doxorubicin (dox)-mediated cellular toxicity
and cellular di¡erentiation [8^11]. RPB11 and RPB3 contain
two amino acid sequences (K motif) with limited homology to
the K subunit of Escherichia coli RNA polymerase, and they
form a heterodimer considered as the functional counterpart
of the bacterial K subunit homodimer involved in promoter
recognition [1,12^15]. In Saccharomyces cerevisiae these two
subunits form with another pol II subunit, RPB2, an inter-
mediate core subassembly analogous to the K2L complex in
the assembly of E. coli RNA polymerase [16]. Interestingly,
mediator complex/pol II interactions are centered on the
RPB11/RPB3 heterodimer [17], and both subunits resulted
highly expressed in adult human skeletal muscle and heart,
suggesting additional role(s) for the heterodimer in these tis-
sues [8,9]. Moreover, multiple alignments of RNA polymerase
K homolog subunits from several organisms have revealed two
additional conserved regions present only in eukaryotic RNA
polymerase and thus considered to be involved in functions
speci¢c for higher organisms [18].
Recently we reported the identi¢cation of the myogenic
factor myogenin as a novel partner for RPB3 [11]. We showed
that ectopic expression of RPB3 increased myogenin transac-
tivation activity, whereas an RPB3 dominant negative mutant
strongly inhibited myogenin activity and muscle di¡erentia-
tion. Notably, we found that RPB3 expression is regulated
during murine C2C7 myoblast cell line di¡erentiation [11].
In a search for additional proteins interacting with RPB3 in
muscle cells, we screened a cDNA library derived from human
skeletal muscle. Three positive interacting clones were identi-
¢ed to be ATF4, a member of the large ATF/CREB tran-
scription factor family not previously shown to directly inter-
act with pol II. ATF/CREB proteins include CREB (cAMP
(cyclic adenosine monophosphate) responsive element binding
protein), CREM (CRE modulator), ATF1, ATF2, ATF3 and
ATF4 [19,20]. These proteins bind to DNA via their basic
region and dimerize via their leucine zipper domain to form
a large variety of homo- and/or heterodimers coordinating
signals from di¡erent cell pathways [19,20]. In particular,
ATF4 was proposed to be a positive regulator of transcription
[21^23], increasing the expression of genes, such as somato-
statin, serotonin, or interleukin-2 [24^26]. We showed that
RPB3 directly binds to ATF4 both in vitro and in vivo and
enhances ATF4 transactivating activity. Moreover, we found
that ATF4 expression as well as RPB3 is modulated during
murine C2C7 myoblast di¡erentiation. Thus, RPB3/ATF4 in-
teraction may play an important role in gene regulation by
ATF4 and in muscle di¡erentiation.
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2. Materials and methods
2.1. Yeast two-hybrid selection
For two-hybrid screening, the complete open reading frame (ORF)
of human RPB3 was cloned into the BamHI restriction site of the
vector pGBKT7 (Clontech, Palo Alto, CA, USA) in frame with the
GAL4 binding domain (BD), and used to screen a human skeletal
muscle cDNA library (Clontech) as previously described [11]. The
recovered library-derived plasmids were analyzed as positive candi-
dates. Liquid Y187 yeast cultures were assayed for L-galactosidase
activity to quantify two-hybrid interactions according to the method
of Schneider et al. [27].
2.2. Plasmids
cDNA coding for the full-length ATF4, isolated by two-hybrid
screening, was cloned into a pCS2-MT myc-tagged mammalian ex-
pression vector, and into pGEX4T3 (Amersham) to generate a gluta-
thione-S-transferase (GST)-ATF4 fusion protein. Full-length human
RPB3 and constructs carrying di¡erent RPB3 deletions, Gal4-Luc
reporter expression vector and pM3-VP16 expression vector contain-
ing the GAL4 DNA BD fused to the VP16 AD were already de-
scribed [11]. To investigate the ATF4 domains involved in the
RPB3 interaction, four GST fusion proteins were constructed in
pGEX4-T1 vector. These four constructs carried di¡erent ATF4 dele-
tions: GST 88^351 (from amino acid 88 to amino acid 351), GST
172^351 (from amino acid 172 to amino acid 351), GST 264^351
(from amino acid 264 to amino acid 351), and GST 1^265 (from
amino acid 1 to amino acid 265). The reporter containing three bind-
ing sites for ATF4 was kindly provided by Dr. Tsonwin Hai (Ohio
State University). All constructs produced were sequenced by Seque-
nase reaction (Amersham) according to the manufacturer’s instruc-
tions.
2.3. Pull-down analysis
BL21 bacterial strains were transformed with GST fusion protein
constructs and the proteins puri¢ed on glutathione-Sepharose resin
(Pharmacia). For in vitro binding assays, comparable amounts of
resin-bound GST fusion proteins were incubated with 500 Wg of cell
lysates in NETN bu¡er (20 mM Tris^HCl, pH 8.0, 100 mM NaCl,
1 mM ethylenediamine tetraacetic acid (EDTA) and 1% NP-40) for 1 h
at 4‡C. The resins were then pelleted and extensively washed in the
same bu¡er. The bound proteins were separated by sodium dodecyl
sulfate^polyacrylamide gel electrophoresis (SDS^PAGE), and the gels
were analyzed by Western blot using anti-RPB3 polyclonal antibody
[11]. Immunoreactivity was detected by enhanced chemiluminescence
(ECL) reaction (Amersham). In vitro transcription and translation
were carried out with tetranitroblue tetrazolium (TNT) coupled retic-
ulocyte lysate systems (Promega) and L-[35S]methionine (s 1000 Ci/
mmol; Amersham) as previously described [11].
2.4. Cell culture and transfections
HeLa human cells and NIH 3T3 mouse ¢broblasts were grown in
Dulbecco’s modi¢ed Eagle’s medium (DMEM) supplemented with
10% fetal calf serum (FCS). C2C7 mouse myoblasts were grown in
DMEM supplemented with 20% fetal bovine serum (GM) until they
reached con£uence. Di¡erentiation was induced by switching to di¡er-
entiation medium (DM), consisting of DMEM containing 2% horse
serum. Transient transfections were performed using lipofectamine
reagent (Gibco BRL) according to the manufacturer’s instructions.
Transfection e⁄ciency ranged between 40 and 60% of cells. The trans-
fection medium was replaced by DMEM supplemented with 10% FCS
18 h after transfection. After incubation for 48 h, luciferase was as-
sayed using reagents from Promega according to the manufacturer’s
instructions. L-Galactosidase was assayed using a L-galactosidase as-
say kit (Tropix).
2.5. Co-immunoprecipitations and immunoblotting
Cells were rinsed three times with ice-cold phosphate bu¡ered saline
(PBS), harvested, centrifuged at 4‡C and cell pellets lysed by incuba-
tion at 4‡C for 30 min in 300 Wl lysis bu¡er (50 mM Tris^HCl, pH 8.0,
150 mM NaCl, 10% glycerol, 0.5 mM EDTA, 0.5 mM ethyleneglycol-
bis-(L-aminoethylether)-N,N,NP,NP-tetraacetic acid (EGTA), 100 mM
NaF, 3 mM Na3VO4, 10 nM okadaic acid, 1 mM phenylmethylsul-
fonyl £uoride (PMSF), 10 mg/ml leupeptin) supplemented with 1%
Fig. 1. RPB3 interacts with ATF4. A: AH109 yeast cells were cotransformed with the indicated constructs and plated onto SD media lacking
leucine and tryptophan (3LW) to verify the expression of both bait (Wþ) and prey (Lþ) plasmids; or onto media lacking leucine, tryptophan,
histidine and adenine (LWHA) for examining the interaction between bait and prey proteins. B: Labeled RPB3 was subjected to GST pull-
down analysis using GST or GST-ATF4 beads. C: Whole cell extracts of HeLa cells transfected with myc-ATF4 or empty myc-tag expression
vectors were immunoprecipitated with anti-myc monoclonal antibody and analyzed by Western blot using anti-RPB3 polyclonal antibody.
D: Whole NIH 3T3 cell extracts were immunoprecipitated with anti-pol II polyclonal antibody or with an irrelevant antibody as control, and
analyzed by Western blot using anti-ATF4 polyclonal antibody.
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NP-40. Supernatants were cleared by centrifugation, pre-cleared using
20 Wl protein A/protein G beads (Santa Cruz, CA, USA), and immu-
noprecipitated by standard procedures using anti-RNA pol II (C-21,
Santa Cruz, CA, USA) polyclonal antibody or anti-myc (9e10, Invi-
trogen) monoclonal antibody [11]. Western blots were prepared by
standard procedures and polyclonal antibodies directed against
RPB3 [11] and ATF4 (Santa Cruz, CA, USA) were used to detect
this protein by chemiluminescence reaction (Amersham). C2C7 mouse
myoblasts were rinsed three times with ice-cold PBS, harvested, cen-
trifuged at 4‡C and cell pellets lysed by incubation at 4‡C for 1 h in
lysis bu¡er. Supernatants were cleared by centrifugation, normalized
for total protein content, subjected to SDS^PAGE, and transferred to
polyvinylidene di£uoride (PVDF) membranes. Blots were incubated
with polyclonal antibodies speci¢c for RPB3 and ATF4, and a mono-
clonal antibody speci¢c for K-tubulin (Sigma).
3. Results and discussion
3.1. RPB3 binds ATF4
Using the yeast two-hybrid system, a cDNA expression
library derived from human skeletal muscle was screened us-
ing RPB3 as bait. Of an estimated 2.5U106 transformants
screened, 30 clones were able to proliferate on media lacking
histidine and adenine and stained positive for L-galactosidase.
These clones were isolated and further characterized. As ex-
pected, several independent clones contained the RPB3 part-
ner, thus con¢rming the speci¢city of the performed screening.
Three independent positive clones encoded for the whole ORF
of the transcription factor ATF4. The remaining clones en-
coded for other transcriptional factors such as the basic helix-
loop-helix myogenic transcription factor myogenin [11] or
were unknown. The speci¢city of RPB3/ATF4 interaction
was con¢rmed in a two-hybrid assay cotransforming ATF4
with either RPB3, or with pGBKT7 empty vector or lamin
control vector (pLAM). As shown in Fig. 1A, RPB3 inter-
acted with ATF4 whereas lamin and pGBKT7 did not show
any signi¢cant interaction, indicating that the observed bind-
ing of RPB3 with ATF4 was speci¢c.
To demonstrate the direct interaction between RPB3 and
ATF4 we performed binding studies between recombinant
RPB3 and ATF4 proteins in vitro. For this purpose, the
ATF4 cDNA insert was cloned in frame into bacterial expres-
sion GST plasmid to obtain GST-ATF4 fusion protein. Then,
GST-ATF4 was tested for the ability to bind in vitro trans-
lated 35S-labeled RPB3. Data shown in Fig. 1B con¢rmed a
speci¢c, direct physical interaction between ATF4 and RPB3.
To provide evidence that RPB3 also associates with ATF4
in vivo, ATF4 cDNA insert was cloned into myc-tagged mam-
malian expression vector and transfected into HeLa cells. As
shown in Fig. 1C, negative control vector Myc-tag showed no
binding to RPB3, whereas immunoprecipitation of tagged
ATF4, followed by Western blot analysis of the precipitates
for the presence of RPB3, indicated a clear interaction be-
tween these two proteins. Next, to evaluate whether ATF4
could be recruited on pol II through its association with
RPB3, we performed a co-immunoprecipitation from NIH
3T3 cell lysates with a polyclonal antibody against the largest
subunit of pol II (RPB1), clearly demonstrating the presence
of ATF4 in pol II complex (Fig. 1D).
The strength of ATF4/RPB3 interaction was further inves-
tigated by yeast LacZ assay comparing its intensity with the
strong structural interaction between RPB11 and RPB3 het-
erodimeric K-like subunits and with the weaker binding of
RPB3 to another transcription factor, myogenin [11]. As ex-
pected, the intensity of the interaction was lower than that of
the two pol II K heterodimeric subunits, but it was compara-
ble to RPB3/myogenin interaction (Fig. 2A). Similar results
were obtained when HeLa cells were transfected with myc-
RPB3 and cell lysates were incubated with GST-RPB11,
GST-myogenin, GST-ATF4 or GST beads (Fig. 2B). Nota-
bly, RPB3 strongly bound to RPB11, but both interactions
with the transcription factors resulted much weaker, support-
ing in such way the hypothesis of a possible role for these
interactions in transcriptional regulation.
3.2. Domains of ATF4 and RPB3 involved in the interaction
To de¢ne the region(s) of RPB3 interacting with ATF4 we
took advantage of RPB3 mutants that were previously de-
scribed [11]. Using these mutants in a pull-down analysis
with 35S-labeled ATF4, we found that two regions of RPB3,
Sud (amino acids 74^138) and Ovest (amino acids 139^197)
(Fig. 3B), were able to contact ATF4 (Fig. 3A). Notably, Sud
contains a Cysteine-rich region that resembles a potential
zinc-¢nger motif [28] and it is necessary for the binding of
RPB3 to myogenin [11], whereas the Ovest region contains
a potential EF-hand calcium BD [9,29]. These regions are
conserved only in eukaryotic pol II and are not present in
the corresponding subunits of pol I and pol III, thus they
can be considered to be involved in function(s) speci¢c for
pol II [1]. Furthermore, it has been demonstrated in yeast
RPB3 that these regions are components of a single determi-
nant speci¢cally required for activator-dependent transcrip-
tion, but not for activator-independent basal transcription
[18]. Then, in order to de¢ne which domain of ATF4 is re-
quired for the interaction with RPB3, three progressive ami-
no-terminal truncated ATF4 derivatives, 88^351, 172^351,
and 264^351 (Fig. 3C) were fused to GST and incubated
with in vitro translated 35S-labeled RPB3. All three constructs
Fig. 2. Interaction analysis of RPB3 with ATF4. A: Y187 yeast
cells were cotransformed with the indicated constructs and assayed
for L-galactosidase activity. B: Whole cell extracts of HeLa cells
transfected with myc-RPB3 were incubated in NETN bu¡er in the
presence of GST, GST-RPB11, GST-myogenin and GST-ATF4
beads as indicated. Recovered interacting proteins were then blotted
and incubated with anti-myc monoclonal antibody.
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retained RPB3 binding capacity (Fig. 3D). In contrast, a con-
struct lacking the last 86 amino acids (Fig. 3C) was unable to
interact with RPB3 (Fig. 3D), indicating that this region is
required in ATF4/RPB3 interaction. Interestingly, the highly
conserved basic leucine zipper domain (bzip) responsible for
transcription activation [21] is present in the carboxy-terminus
of ATF4.
3.3. RPB3 enhances ATF4-mediated transactivation
The result that RPB3 contacts the bzip region of ATF4 led
us to hypothesize that the interaction between RPB3 and
ATF4 can be directly involved in transactivating activity of
ATF4. To test this hypothesis, ATF4 and RPB3 mammalian
expression plasmids were cotransfected with a luciferase re-
porter driven by tandem ATF4 sites into HeLa cells. As
shown in Fig. 4A, overexpression of ATF4 activated the re-
porter more than 10-fold whereas cotransfection of RPB3
resulted in a three-fold enhancement of ATF4 activation; no
e¡ects were observed when RPB3 was coexpressed with an-
other activator like VP16 together with a Gal4 luciferase re-
porter (Fig. 4B). Consistent with these results, cotransfection
experiments performed using a dominant negative deletion
mutant of RPB3, Sud [7], demonstrated that expression of
Sud markedly inhibited reporter activation (Fig. 4A), thus
con¢rming an involvement of RPB3 in ATF4-mediated trans-
activation.
3.4. ATF4 expression is modulated during murine C2C7
myoblast di¡erentiation
We have previously shown that RPB3 is highly expressed in
human skeletal muscle [9], and that RPB3/myogenin interac-
tion is important for muscle conversion of murine C3H10T1/2
cells [11]. These observations prompted us to analyze ATF4
protein level during the onset of di¡erentiation of murine
C2C7 myoblasts. Fig. 5 shows that ATF4 had the same ex-
pression pattern as RPB3 [11]. Indeed, ATF4 was detectable
at all stages of di¡erentiation, but with signi¢cant di¡erent
level of expression: the level was low in cycling C2C7 cells,
but increased about three-fold in high density orientated cells
(concomitantly with the beginning of di¡erentiation program).
These data further suggest that the interaction ATF4/RPB3
could play a crucial role in muscle di¡erentiation.
In summary, the data presented in this paper describe a
novel interaction between a pol II subunit, RPB3 and the
transcription factor ATF4, supporting in such way the hy-
pothesis that RPB3, in addition to the well-described struc-
Fig. 3. Domain analysis of RPB3 and ATF4. A: 35S-labeled ATF4 was utilized in pull-down analysis with several deletions of RPB3 fused to
GST. B: Schematic representation of the RPB3 deletions employed in the experiments reported in A. C: Schematic representation of ATF4
showing the nested deletion constructs. The horizontal bars represent the amino acid sequence in each construct. D: 35S-labeled RPB3 was uti-
lized in pull-down analysis with the deletions of ATF4 fused to GST depicted in C.
Fig. 4. RPB3 is involved in ATF4-mediated transcription. HeLa
cells were transiently transfected with 0.2 Wg of the 3xATF4-Luc re-
porter (A), Gal4-Luc reporter (B), and 1 Wg of the indicated expres-
sion vectors. Data are presented as the meansTS.D. from three in-
dependent experiments performed in duplicate.
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tural function, is also involved in the regulation of transcrip-
tion. Indeed, RPB3 is able to directly bind transcription fac-
tors and the region involved in these interactions is conserved
only in pol II and is not present in the corresponding subunits
of pol I and pol III, thus suggesting that it could exert func-
tion(s) speci¢c for pol II.
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Fig. 5. Expression of ATF4 is modulated during muscle di¡erentia-
tion. Total lysates from C2C7 cells incubated in DM for the indi-
cated times, or maintained in GM, were blotted and incubated with
the indicated antibodies.
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